Search research articles
Contact Us
Filters
Showing results (61-70 of 94) with videos related to
Page
of 10
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
December 3, 2024
Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia
Moritz B Bastian, Maike Sieben, Arne Blickle, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 26, 2025
Expanding the scope of PSMA-RLT: evaluating treatment in challenging mCRPC patients with poor performance status (ECOG 3)
Moritz B Bastian, Benedikt Wörl, Arne Blickle, et al.
Cancer
|
August 1, 1993
Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients
H Drepper, C O Köhler, B Bastian, et al.
Cancers
|
August 10, 2024
Analysis of Molecular Imaging and Laboratory Baseline Biomarkers in PSMA-RLT: Whole-Body Total Lesion PSMA (TLP) Predicts Overall Survival
Connor Hein, Caroline Burgard, Arne Blickle, et al.
European Radiology Experimental
|
September 25, 2023
Feasibility of the chick chorioallantoic membrane model for preclinical studies on tumor radiofrequency ablation
Joel Wessendorf, Michael Scheschenja, Moritz B Bastian, et al.
Current Oncology (Toronto, Ont.)
|
June 25, 2026
Automated PROMISE V2 Scoring from PSMA PET/CT Reports Using Large Language Models: A Comparative Evaluation of Prompt Design and Model Performance
Tilman Speicher, Isa Ethem Demirkol, Arne Blickle, et al.
Pigment Cell & Melanoma Research
|
December 23, 2009
Melanoma from bench to bedside: meeting report from the 6th international melanoma congress
D E Fisher, R Barnhill, F S Hodi, et al.
Clinical Nuclear Medicine
|
May 13, 2025
PSMA Radioligand Therapy in Advanced Age: Insights From an 85y+ mCRPC Patient Cohort
Moritz B Bastian, Benedikt Wörl, Arne Blickle, et al.
EJNMMI Research
|
July 6, 2025
Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopenia
Moritz B Bastian, Tilman Speicher, Arne Blickle, et al.
Clinical Nuclear Medicine
|
November 27, 2024
Outcome and Renal Safety of PSMA-Targeted Radioligand Therapy in mCRPC Patients With Preexisting Impaired Renal Function
Moritz B Bastian, Maike Sieben, Caroline Burgard, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 94) with videos related to
Sort By:
Page
of 10
European Journal of Nuclear Medicine and Molecular Imaging
|
December 3, 2024
Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia
Moritz B Bastian, Maike Sieben, Arne Blickle, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 26, 2025
Expanding the scope of PSMA-RLT: evaluating treatment in challenging mCRPC patients with poor performance status (ECOG 3)
Moritz B Bastian, Benedikt Wörl, Arne Blickle, et al.
Cancer
|
August 1, 1993
Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients
H Drepper, C O Köhler, B Bastian, et al.
Cancers
|
August 10, 2024
Analysis of Molecular Imaging and Laboratory Baseline Biomarkers in PSMA-RLT: Whole-Body Total Lesion PSMA (TLP) Predicts Overall Survival
Connor Hein, Caroline Burgard, Arne Blickle, et al.
European Radiology Experimental
|
September 25, 2023
Feasibility of the chick chorioallantoic membrane model for preclinical studies on tumor radiofrequency ablation
Joel Wessendorf, Michael Scheschenja, Moritz B Bastian, et al.
Current Oncology (Toronto, Ont.)
|
June 25, 2026
Automated PROMISE V2 Scoring from PSMA PET/CT Reports Using Large Language Models: A Comparative Evaluation of Prompt Design and Model Performance
Tilman Speicher, Isa Ethem Demirkol, Arne Blickle, et al.
Pigment Cell & Melanoma Research
|
December 23, 2009
Melanoma from bench to bedside: meeting report from the 6th international melanoma congress
D E Fisher, R Barnhill, F S Hodi, et al.
Clinical Nuclear Medicine
|
May 13, 2025
PSMA Radioligand Therapy in Advanced Age: Insights From an 85y+ mCRPC Patient Cohort
Moritz B Bastian, Benedikt Wörl, Arne Blickle, et al.
EJNMMI Research
|
July 6, 2025
Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopenia
Moritz B Bastian, Tilman Speicher, Arne Blickle, et al.
Clinical Nuclear Medicine
|
November 27, 2024
Outcome and Renal Safety of PSMA-Targeted Radioligand Therapy in mCRPC Patients With Preexisting Impaired Renal Function
Moritz B Bastian, Maike Sieben, Caroline Burgard, et al.
Page
of 10